Programmed Cell Death 1 Ligand 2 Protein
"Programmed Cell Death 1 Ligand 2 Protein" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A costimulatory B7 antigen that has specificity for the T-CELL receptor PROGRAMMED CELL DEATH 1 RECEPTOR. It is closely-related to CD274 antigen; however, its expression is restricted to DENDRITIC CELLS and activated MACROPHAGES.
|Programmed Cell Death 1 Ligand 2 Protein
- Programmed Cell Death 1 Ligand 2 Protein
- CD273 Antigen
- Antigen, CD273
- PD-L2 Ligand
- Ligand, PD-L2
- PD L2 Ligand
- B7-DC Ligand
- B7 DC Ligand
- Ligand, B7-DC
- Antigens, CD273
- CD273 Antigens
- B7-DC Antigen
- Antigen, B7-DC
- B7 DC Antigen
Below are MeSH descriptors whose meaning is more general than "Programmed Cell Death 1 Ligand 2 Protein".
Below are MeSH descriptors whose meaning is more specific than "Programmed Cell Death 1 Ligand 2 Protein".
This graph shows the total number of publications written about "Programmed Cell Death 1 Ligand 2 Protein" by people in this website by year, and whether "Programmed Cell Death 1 Ligand 2 Protein" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Programmed Cell Death 1 Ligand 2 Protein" by people in Profiles.
Exome sequencing identifies PD-L2 as a potential predisposition gene for lymphoma. Hematol Oncol. 2022 Aug; 40(3):475-478.
Indoleamine 2,3-Dioxygenase-1 Expression in Adrenocortical Carcinoma. J Surg Res. 2020 12; 256:90-95.
Expression of programmed death ligand 1 and 2 in adrenocortical cancer tissues: An exploratory study. Surgery. 2019 01; 165(1):196-201.
Patterns of PD-1, PD-L1, and PD-L2 expression in pediatric solid tumors. Pediatr Blood Cancer. 2017 Nov; 64(11).
Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 03 16; 543(7645):378-384.
Cutting Edge: CTLA-4Ig Inhibits Memory B Cell Responses and Promotes Allograft Survival in Sensitized Recipients. J Immunol. 2015 Nov 01; 195(9):4069-73.
Negative regulation of T-cell function by PD-1. Crit Rev Immunol. 2004; 24(4):229-37.
B7DC/PDL2 promotes tumor immunity by a PD-1-independent mechanism. J Exp Med. 2003 Jun 16; 197(12):1721-30.